On May 7, 2014, the OFCCP published Directive 2014-01, which establishes a five-year moratorium on its enforcement of obligations related to affirmative action programs and recordkeeping under Executive Order (E.O.) 11246, Section 503 of the Rehabilitation Act of 1973 (Section 503), and the Vietnam Era Veterans’ Readjustment Assistance Act of […]
Health Law Alert
Iowa Broadens Security Breach Notification Provisions
on Friday, 27 June 2014 in
Health Law Alert: Erin E. Busch, Editor
On April 3, 2014, Iowa Governor Terry Branstad signed into law Senate File 2259, amending the state’s personal information security breach notification requirements. The revised Iowa Code Chapter 715C expands the definitions of key terms, including “breach of security” and “personal information,” and establishes an Attorney General notification requirement for […]
CMS SRDP Settlements Announced
on Wednesday, 18 June 2014 in
Health Law Alert: Erin E. Busch, Editor
Two submissions under the Self-Referral Disclosure Protocol (SRDP) reporting possible violations of the Stark Law were settled by CMS on December 23, 2013. As reported by CMS on its website, the first submission involved an acute care hospital in Florida, which disclosed that its arrangement with 51 physicians failed to […]
And the Money Keeps Rolling in … Recent HIPAA Settlements and the Focus on Encryption
on Wednesday, 11 June 2014 in
Health Law Alert: Erin E. Busch, Editor
Note: This is the first article in a 2-part series on HIPAA and data security and encryption. The June edition of the Health Law Advisory will include an article by James E. O’Connor of the Technology and Intellectual Property Practice Group. Four recent settlement agreements between health care organizations and […]
The End of 340B Discounts for Orphan Drugs: Court Rules HHS Without Authority to Promulgate Orphan Drug Exclusion
on Friday, 6 June 2014 in
Health Law Alert: Erin E. Busch, Editor
On May 23, 2014, a federal district court invalidated the 340B Program’s orphan drug exclusion after finding that the U.S. Department of Health and Human Services (HHS) acted beyond its statutory authority when it implemented the rule. The 340B Program requires manufacturers to give substantial discounts on outpatient prescription drugs […]
